106 related articles for article (PubMed ID: 3693868)
1. Correlates of early neuroleptic response using a uniform haloperidol dose.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
[TBL] [Abstract][Full Text] [Related]
2. Plasma catecholamine metabolites and early response to haloperidol.
Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
[TBL] [Abstract][Full Text] [Related]
3. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
[TBL] [Abstract][Full Text] [Related]
4. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
5. Ratio of serum prolactin to haloperidol and early clinical outcome in acute psychosis.
Swigar ME; Jatlow PI; Goicoechea N; Opsahl C; Bowers MB
Am J Psychiatry; 1984 Oct; 141(10):1281-3. PubMed ID: 6486269
[TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
[TBL] [Abstract][Full Text] [Related]
7. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
[No Abstract] [Full Text] [Related]
8. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
Aschauer HN; Schönbeck G; Langer G; Koinig G; Resch F; Hatzinger R; Chaudry HR; Sieghart W
Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in plasma homovanillic acid in acute psychosis.
Bowers MB; Swigar ME; Jatlow PI
N Engl J Med; 1983 Apr; 308(14):845-6. PubMed ID: 6835278
[No Abstract] [Full Text] [Related]
10. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
Shostak M; Perel JM; Stiller RL; Wyman W; Curran S
J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700
[TBL] [Abstract][Full Text] [Related]
11. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
Mazure CM; Nelson JC; Jatlow PI; Bowers MB
Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
[TBL] [Abstract][Full Text] [Related]
12. Recent life stressors and biological markers in newly admitted psychotic patients.
Mazure CM; Quinlan DM; Bowers MB
Biol Psychiatry; 1997 Apr; 41(8):865-70. PubMed ID: 9099413
[TBL] [Abstract][Full Text] [Related]
13. Influence of route of administration on haloperidol plasma levels in psychotic patients.
Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
[TBL] [Abstract][Full Text] [Related]
14. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
[TBL] [Abstract][Full Text] [Related]
15. Utility of neuroleptic blood levels in the treatment of acute psychosis.
Zohar J; Shemesh Z; Belmaker RH
J Clin Psychiatry; 1986 Dec; 47(12):600-3. PubMed ID: 3782046
[TBL] [Abstract][Full Text] [Related]
16. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
[TBL] [Abstract][Full Text] [Related]
17. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG.
Bowers MB; Swigar ME; Jatlow PI; Hoffman F; Giocoechea N
Compr Psychiatry; 1986; 27(3):181-5. PubMed ID: 2872015
[No Abstract] [Full Text] [Related]
18. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG
Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
[TBL] [Abstract][Full Text] [Related]
19. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]